Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Acting Chief Financial Officer | $227M | -$45M | -16.5% | Jun 3, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|